Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptor fibroblast growth factor, type 2
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Most Relevant Literature
- Build to understand biliary oncogenesis via organoids and FGFR2 fusion proteins.
- Keratinocyte growth factor binding to fibroblast growth factor receptor 2-IIIb promotes epithelial o…
- FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 …
- Expression level of FGFR2 protein in patients with esophageal cancer and those with Barrett's esopha…
- Surgical Result and Identification of FGFR2 Variants Using Whole-Exome Sequencing in a Chinese Famil…
Most Relevant Clinical Trials
- Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease
- Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Trans…
- Characterizing Gingival and Periodontal Ligament Fibroblasts Reaction to Infection With the Bacteria…
- Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone I…
- Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
